Co-Diagnostics (CODX) Stock Price, Quote, News & History | Benzinga

Co-Diagnostics Inc (CODX) Stock Price, Quote, News & History

CODXNASDAQ

Trade with Public

Trade with Public

$1.51

N/A

At close: Aug 5, 5:00 PM EST

$1.47

-0.04-2.65%

After Hours: 7:25 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.50

Close

$1.51

Volume / Avg.

149.73K / 5.67M

Day Range

$1.43 - $1.53

52 Wk Range

1.26 - 46.50

Market Cap

$5.42M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

30

Short Interest

9.62%

Days to Cover

1

Recent Co-Diagnostics Inc News

Merck-Backed Lab Gets $8.5 Million to Fast-Track a Vaccine for a Rapidly Spreading Ebola Outbreak

Merck and Wellcome-backed Hilleman will manufacture Bundibugyo Ebola vaccine doses for clinical trials with up to $8.5M in CEPI funding.

Tanya Rawat

EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test

Co-Diagnostics advances its Ebola testing capabilities, sending Bundibugyo virus test kits for evaluation and completing a new assay study.

Vandana Singh

Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket

Forte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans to acquire the company for $77 per share.

Avi Kapoor

EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin

Co-Diagnostics' India joint venture CoSara has started clinical studies for its rapid TB PCR test, advancing deployment of its point-of-care platform.

Vandana Singh

EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform

Co-Diagnostics completed clinical and analytical studies for its PCR Flu A/B & RSV test and plans FDA 510(k) and CLIA waiver submissions.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-28.24M

Investing Cash Flow (TTM)

18.77M

Financing Cash Flow (TTM)

15.79M

Free Cash Flow (TTM)

-28.99M

Capital Expenditure (TTM)

-750.15K

Net Change in Cash (TTM)

6.33M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$635.81K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.42

PB Ratio (TTM)

0.35

Earnings Yield % (TTM)

-2136.42%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.35

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$8.23M

Debt to Equity

0.13

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.50

Close

$1.51

Volume / Avg.

149.73K / 5.67M

Day Range

$1.43 - $1.53

52 Wk Range

1.26 - 46.50

Market Cap

$5.42M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

30

Short Interest

9.62%

Days to Cover

1

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), includi...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Co-Diagnostics (CODX) stock?

A

You can purchase shares of Co-Diagnostics (NASDAQ:CODX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Co-Diagnostics (CODX) competitors?

A

There are no as such competitors for Co-Diagnostics.

Q

What is the forecast, or price target, for Co-Diagnostics (CODX) stock?

A

Co-Diagnostics has a consensus price target of $3.00.

Q

What is the current price for Co-Diagnostics (CODX)?

A

The stock price for Co-Diagnostics (NASDAQ: CODX) is $1.47 last updated August 5, 2026 at 7:25 PM EDT.

Q

Does Co-Diagnostics (CODX) pay a dividend?

A

There are no upcoming dividends for Co-Diagnostics.

Q

When is Co-Diagnostics (NASDAQ:CODX) reporting earnings?

A

Co-Diagnostics does not have any upcoming earnings scheduled.

Q

Is Co-Diagnostics (CODX) going to split?

A

There is no upcoming split for Co-Diagnostics.

Q

What sector and industry does Co-Diagnostics (CODX) operate in?

A

Co-Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.